30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Allergan plc (AGN)

Track

Stock chart
Ticker: AGN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SAUNDERS BRENT L
Chairman, President and CEO
3 purchases — total 252,858 USD
Buy 7 Mar 2019
Value US$3,831,942.38 | Price 294.47 | Shares 61,640
Buy 7 Mar 2019
Value US$4,374,212.08 | Price 146.27 | Shares 58,076
Buy 7 Mar 2019
Value US$42,654.00 | Price 142.18 | Shares 300
Buy 16 Nov 2018
Value US$2,030,895.41 | Price 117.64 | Shares 92,415
Buy 6 Sep 2018
Value US$57,189.00 | Price 190.63 | Shares 300
Buy 6 Sep 2018
Value US$98,560.88 | Price 190.64 | Shares 517
Buy 6 Sep 2018
Value US$932,234.52 | Price 190.68 | Shares 4,889
Buy 6 Sep 2018
Value US$42,328.74 | Price 190.67 | Shares 222
Buy 6 Sep 2018
Value US$155,578.56 | Price 190.66 | Shares 816
Buy 6 Sep 2018
Value US$19,065.00 | Price 190.65 | Shares 100
Buy 6 Sep 2018
Value US$12,962.16 | Price 190.62 | Shares 68
Buy 6 Sep 2018
Value US$38,122.00 | Price 190.61 | Shares 200
Buy 6 Sep 2018
Value US$76,240.00 | Price 190.60 | Shares 400
Buy 6 Sep 2018
Value US$67,850.04 | Price 190.59 | Shares 356
Buy 6 Sep 2018
Value US$19,058.00 | Price 190.58 | Shares 100
Buy 6 Sep 2018
Value US$5,145.39 | Price 190.57 | Shares 27
Buy 6 Sep 2018
Value US$134,344.80 | Price 190.56 | Shares 705
Buy 6 Sep 2018
Value US$247,715.00 | Price 190.55 | Shares 1,300
Buy 30 Aug 2018
Value US$171,531.00 | Price 190.59 | Shares 900
Buy 30 Aug 2018
Value US$209,759.00 | Price 190.69 | Shares 1,100
Sale 30 Aug 2018
Value US$200,502.75 | Price 190.05 | Shares 1,055
Planned sale 17 May 2018
Value US$3,775,860.75 | Price 154.59 | Shares 24,425
Buy 15 Mar 2018
Value US$149,814.05 | Price 167.39 | Shares 895
Buy 8 Mar 2018
Value US$153,960.00 | Price 153.96 | Shares 1,000
Buy 8 Mar 2018
Value US$503,349.00 | Price 152.53 | Shares 3,300
Buy 5 Mar 2018
Value US$129,078.00 | Price 143.42 | Shares 900
Buy 21 Feb 2018
Value US$321,880.00 | Price 160.94 | Shares 2,000
Sale 14 Feb 2018
Value US$2,246,176.00 | Price 165.16 | Shares 13,600
Sale 14 Feb 2018
Value US$329,240.00 | Price 164.62 | Shares 2,000
Sale 14 Feb 2018
Value US$1,173,888.00 | Price 163.04 | Shares 7,200
Sale 14 Feb 2018
Value US$762,434.00 | Price 162.22 | Shares 4,700
Sale 14 Feb 2018
Value US$161,100.00 | Price 161.10 | Shares 1,000
Sale 14 Feb 2018
Value US$383,568.00 | Price 159.82 | Shares 2,400
Sale 14 Feb 2018
Value US$269,926.00 | Price 158.78 | Shares 1,700
Sale 14 Feb 2018
Value US$189,120.00 | Price 157.60 | Shares 1,200
Sale 14 Feb 2018
Value US$3,941,917.22 | Price 157.18 | Shares 25,079
Buy 7 Dec 2017
Value US$499,253.10 | Price 164.77 | Shares 3,030
Buy 6 Dec 2017
Value US$33,070.00 | Price 165.35 | Shares 200
Buy 6 Dec 2017
Value US$724,724.00 | Price 164.71 | Shares 4,400
Buy 5 Dec 2017
Value US$1,633,000.00 | Price 163.30 | Shares 10,000
Sale 1 Dec 2017
Value US$440,811.15 | Price 173.89 | Shares 2,535
Sale 1 Dec 2017
Value US$1,612,308.08 | Price 173.89 | Shares 9,272
Buy 16 Jun 2017
Value US$10,327.50 | Price 235.96 | Shares 44
Sale 18 May 2017
Value US$416,430.05 | Price 220.45 | Shares 1,889
Buy 29 Mar 2017
Value US$10,298.77 | Price 242.21 | Shares 43
Sale 2 Mar 2017
Value US$588,956.40 | Price 248.40 | Shares 2,371
Sale 2 Mar 2017
Value US$6,856,379.44 | Price 247.63 | Shares 27,688
Sale 2 Mar 2017
Value US$2,038,972.88 | Price 246.64 | Shares 8,267
Sale 2 Mar 2017
Value US$7,783,252.02 | Price 245.73 | Shares 31,674
Sale 8 Dec 2016
Value US$94,360.00 | Price 188.72 | Shares 500
Buy 21 Nov 2016
Value US$992,940.90 | Price 189.13 | Shares 5,250
Buy 11 Nov 2016
Value US$149,792.62 | Price 208.05 | Shares 720
Buy 11 Nov 2016
Value US$149,743.62 | Price 213.31 | Shares 702
Sale 5 Aug 2016
Value US$191,789.16 | Price 253.02 | Shares 758
Buy 2 Jun 2016
Value US$159,677.77 | Price 241.57 | Shares 661
Sale 11 May 2016
Value US$103,320.90 | Price 225.10 | Shares 459
Sale 7 Dec 2015
Value US$719,808.00 | Price 312.96 | Shares 2,300
Buy 24 Aug 2015
Value US$297,421.50 | Price 297.42 | Shares 1,000
Buy 21 Aug 2015
Value US$301,940.00 | Price 301.94 | Shares 1,000
Sale 9 Jun 2015
Value US$655,358.00 | Price 297.89 | Shares 2,200
Sale 26 Nov 2014
Value US$1,224,606.56 | Price 269.14 | Shares 4,550
Sale 8 Sep 2014
Value US$1,530,914.58 | Price 230.49 | Shares 6,642
Sale 13 Dec 2013
Value US$111,797.00 | Price 159.71 | Shares 700
Sale 13 Dec 2013
Value US$31,934.00 | Price 159.67 | Shares 200
Sale 13 Dec 2013
Value US$335,286.00 | Price 159.66 | Shares 2,100
Sale 9 Dec 2013
Value US$1,328,160.00 | Price 166.02 | Shares 8,000
Sale 6 Dec 2013
Value US$1,179,736.00 | Price 166.16 | Shares 7,100
Sale 6 Dec 2013
Value US$1,241,325.00 | Price 165.51 | Shares 7,500
Sale 5 Dec 2013
Value US$42,881.52 | Price 162.43 | Shares 264
Sale 2 Dec 2013
Value US$978,060.00 | Price 163.01 | Shares 6,000
Sale 27 Nov 2013
Value US$3,995,805.00 | Price 165.00 | Shares 24,217
Sale 26 Nov 2013
Value US$1,626,000.00 | Price 162.60 | Shares 10,000
Sale 25 Nov 2013
Value US$247,830.00 | Price 165.00 | Shares 1,502
Sale 22 Nov 2013
Value US$408,625.00 | Price 163.45 | Shares 2,500
Sale 22 Nov 2013
Value US$706,365.00 | Price 165.00 | Shares 4,281
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-03-07 2019-03-07 B Purchase
3.1
SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
61,640 +9.3%
294.47
US$3,831,942 		61,640 +9.3% 294.47 US$3,831,942
2019-03-07 2019-03-07 B Purchase
3.1
SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
58,076 -45.8%
146.27
US$4,374,212 		58,076 -45.8% 146.27 US$4,374,212
2019-03-07 2019-03-07 B Purchase
3.1
SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
21,372 +20.9%
249.15
US$4,775,406 		21,372 +20.9% 249.15 US$4,775,406
2018-11-19 2018-11-16 B Purchase WALSH MATTHEW M

EVP, Chief Financial Officer

Officer
1,000 +3.9%
157.00
US$157,000 		1,000 +3.9% 157.00 US$157,000
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
300 +1.9%
190.63
US$57,189 		300 +1.9% 190.63 US$57,189
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
517 +3.3%
190.64
US$98,561 		517 +3.3% 190.64 US$98,561
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
4,889 +45.6%
190.68
US$932,235 		4,889 +45.6% 190.68 US$932,235
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
222 +2.1%
190.67
US$42,329 		222 +2.1% 190.67 US$42,329
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
816 +8.4%
190.66
US$155,579 		816 +8.4% 190.66 US$155,579
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
100 +1.0%
190.65
US$19,065 		100 +1.0% 190.65 US$19,065
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
68 +0.7%
190.62
US$12,962 		68 +0.7% 190.62 US$12,962
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
200 +2.1%
190.61
US$38,122 		200 +2.1% 190.61 US$38,122
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
400 +4.5%
190.60
US$76,240 		400 +4.5% 190.60 US$76,240
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
356 +4.2%
190.59
US$67,850 		356 +4.2% 190.59 US$67,850
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
100 +1.2%
190.58
US$19,058 		100 +1.2% 190.58 US$19,058
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
27 +0.3%
190.57
US$5,145 		27 +0.3% 190.57 US$5,145
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
705 +9.1%
190.56
US$134,345 		705 +9.1% 190.56 US$134,345
2018-09-07 2018-09-06 B Purchase COUGHLIN CHRISTOPHER J Non-Executive Director
1,300 +20.2%
190.55
US$247,715 		1,300 +20.2% 190.55 US$247,715
2018-09-04 2018-08-30 B Purchase Boccuzi Joseph H Non-Executive Director
900 +30.2%
190.59
US$171,531 		900 +30.2% 190.59 US$171,531
2018-09-04 2018-08-30 B Purchase FREYMAN THOMAS C Non-Executive Director
1,100 +70.6%
190.69
US$209,759 		1,100 +70.6% 190.69 US$209,759
2018-09-04 2018-08-30 S Sale Basgoz Nesli Non-Executive Director
1,055 -12.5%
190.05
US$200,503 		1,055 -12.5% 190.05 US$200,503
2018-05-21 2018-05-17 PlS Planned sale Meury William

EVP & Chief Commercial Officer

Officer
24,425 -60.8%
154.59
US$3,775,861 		24,425 -60.8% 154.59 US$3,775,861
2018-03-19 2018-03-15 B Purchase Hilado Maria Teresa

Executive Vice President
895 +3.5%
167.39
US$149,814 		895 +3.5% 167.39 US$149,814
2018-03-08 2018-03-08 B Purchase WALSH MATTHEW M

EVP, Chief Financial Officer
1,000 +4.1%
153.96
US$153,960 		1,000 +4.1% 153.96 US$153,960
2018-03-08 2018-03-08 B Purchase SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
3,300 +1.9%
152.53
US$503,349 		3,300 +1.9% 152.53 US$503,349
2018-03-09 2018-03-05 B Purchase Boccuzi Joseph H
900 +93.6%
143.42
US$129,078 		900 +93.6% 143.42 US$129,078
2018-02-22 2018-02-21 B Purchase WALSH MATTHEW M

EVP, Chief Financial Officer

Officer
2,000 +8.9%
160.94
US$321,880 		2,000 +8.9% 160.94 US$321,880
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
13,600 -40.8%
165.16
US$2,246,176 		13,600 -40.8% 165.16 US$2,246,176
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
2,000 -5.7%
164.62
US$329,240 		2,000 -5.7% 164.62 US$329,240
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
7,200 -16.9%
163.04
US$1,173,888 		7,200 -16.9% 163.04 US$1,173,888
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
4,700 -10.0%
162.22
US$762,434 		4,700 -10.0% 162.22 US$762,434
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
1,000 -2.1%
161.10
US$161,100 		1,000 -2.1% 161.10 US$161,100
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
2,400 -4.7%
159.82
US$383,568 		2,400 -4.7% 159.82 US$383,568
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
1,700 -3.2%
158.78
US$269,926 		1,700 -3.2% 158.78 US$269,926
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
1,200 -2.2%
157.60
US$189,120 		1,200 -2.2% 157.60 US$189,120
2018-02-16 2018-02-14 S Sale Meury William

Chief Commercial Officer

Officer
25,079 -31.9%
157.18
US$3,941,917 		25,079 -31.9% 157.18 US$3,941,917
2017-12-07 2017-12-07 B Purchase BODINE CHRIS W
3,030 +21.5%
164.77
US$499,253 		3,030 +21.5% 164.77 US$499,253
2017-12-06 2017-12-06 B Purchase SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
200 +0.1%
165.35
US$33,070 		200 +0.1% 165.35 US$33,070
2017-12-06 2017-12-06 B Purchase SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
4,400 +2.4%
164.71
US$724,724 		4,400 +2.4% 164.71 US$724,724
2017-12-05 2017-12-05 B Purchase COUGHLIN CHRISTOPHER J
10,000 +224.9%
163.30
US$1,633,000 		10,000 +224.9% 163.30 US$1,633,000
2017-12-04 2017-12-01 S Sale Meury William

Chief Commercial Officer
2,535 -4.3%
173.89
US$440,811 		2,535 -4.3% 173.89 US$440,811
2017-12-04 2017-12-01 S Sale Meury William

Chief Commercial Officer
9,272 -13.5%
173.89
US$1,612,308 		9,272 -13.5% 173.89 US$1,612,308
2017-09-18 2017-06-16 B Purchase SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
44 +0.0%
235.96
US$10,327 		44 +0.0% 235.96 US$10,327
2017-05-22 2017-05-18 S Sale Basgoz Nesli Non-Executive Director
1,889 -23.9%
220.45
US$416,430 		1,889 -23.9% 220.45 US$416,430
2017-09-18 2017-03-29 B Purchase SAUNDERS BRENT L

Chairman, President and CEO

Executive Director
43 +0.0%
242.21
US$10,299 		43 +0.0% 242.21 US$10,299
2017-03-06 2017-03-02 S Sale BISARO PAUL Non-Executive Director
2,371 -1.0%
248.40
US$588,956 		2,371 -1.0% 248.40 US$588,956
2017-03-06 2017-03-02 S Sale BISARO PAUL Non-Executive Director
27,688 -10.4%
247.63
US$6,856,379 		27,688 -10.4% 247.63 US$6,856,379
2017-03-06 2017-03-02 S Sale BISARO PAUL Non-Executive Director
8,267 -3.0%
246.64
US$2,038,973 		8,267 -3.0% 246.64 US$2,038,973
2017-03-06 2017-03-02 S Sale BISARO PAUL Non-Executive Director
31,674 -10.4%
245.73
US$7,783,252 		31,674 -10.4% 245.73 US$7,783,252
2016-12-09 2016-12-08 S Sale Basgoz Nesli Non-Executive Director
500 -8.3%
188.72
US$94,360 		500 -8.3% 188.72 US$94,360
2016-11-21 2016-11-21 B Purchase SAUNDERS BRENT L

CEO and President

Executive Director
5,250 +5.2%
189.13
US$992,941 		5,250 +5.2% 189.13 US$992,941
2016-11-15 2016-11-11 B Purchase Hilado Maria Teresa

Chief Financial Officer

Officer
720 +5.7%
208.05
US$149,793 		720 +5.7% 208.05 US$149,793
2016-11-15 2016-11-11 B Purchase Hilado Maria Teresa

Chief Financial Officer

Officer
702 +5.9%
213.31
US$149,744 		702 +5.9% 213.31 US$149,744
2016-08-09 2016-08-05 S Sale Basgoz Nesli Non-Executive Director
758 -11.4%
253.02
US$191,789 		758 -11.4% 253.02 US$191,789
2016-06-06 2016-06-02 B Purchase Hilado Maria Teresa

Chief Financial Officer

Officer
661 +5.9%
241.57
US$159,678 		661 +5.9% 241.57 US$159,678
2016-05-12 2016-05-11 S Sale Basgoz Nesli Non-Executive Director
459 -8.8%
225.10
US$103,321 		459 -8.8% 225.10 US$103,321
2015-12-09 2015-12-07 S Sale Basgoz Nesli Non-Executive Director
2,300 -36.2%
312.96
US$719,808 		2,300 -36.2% 312.96 US$719,808
2015-08-24 2015-08-24 B Purchase BISARO PAUL

Exec Chairman

Executive Director
1,000 +0.2%
297.42
US$297,422 		1,000 +0.2% 297.42 US$297,422
2015-08-24 2015-08-21 B Purchase SAUNDERS BRENT L

CEO and President

Executive Director
1,000 +0.8%
301.94
US$301,940 		1,000 +0.8% 301.94 US$301,940
2015-06-10 2015-06-09 S Sale Basgoz Nesli Non-Executive Director
2,200 -33.9%
297.89
US$655,358 		2,200 -33.9% 297.89 US$655,358
2014-12-01 2014-11-26 S Sale Meury William

See Remarks

Officer
4,550 -5.3%
269.14
US$1,224,607 		4,550 -5.3% 269.14 US$1,224,607
2014-09-10 2014-09-08 S Sale PAONESSA ALBERT III

President Anda, Inc.

Officer
6,642 -23.3%
230.49
US$1,530,915 		6,642 -23.3% 230.49 US$1,530,915
2013-12-16 2013-12-13 S Sale BODINE CHRIS W Non-Executive Director
700 -5.7%
159.71
US$111,797 		700 -5.7% 159.71 US$111,797
2013-12-16 2013-12-13 S Sale BODINE CHRIS W Non-Executive Director
200 -1.6%
159.67
US$31,934 		200 -1.6% 159.67 US$31,934
2013-12-16 2013-12-13 S Sale BODINE CHRIS W Non-Executive Director
2,100 -14.4%
159.66
US$335,286 		2,100 -14.4% 159.66 US$335,286
2013-12-10 2013-12-09 S Sale Stewart Robert A

Pres-Global Operations

Officer
8,000 -16.2%
166.02
US$1,328,160 		8,000 -16.2% 166.02 US$1,328,160
2013-12-06 2013-12-06 S Sale JOYCE R TODD

CFO-Global

Officer
7,100 -15.1%
166.16
US$1,179,736 		7,100 -15.1% 166.16 US$1,179,736
2013-12-06 2013-12-06 S Sale JOYCE R TODD

CFO-Global

Officer
7,500 -13.7%
165.51
US$1,241,325 		7,500 -13.7% 165.51 US$1,241,325
2013-12-09 2013-12-05 S Sale TURNER ANDREW L Non-Executive Director
264 -100.0%
162.43
US$42,882 		264 -100.0% 162.43 US$42,882
2013-12-04 2013-12-02 S Sale TAYLOR RONALD R Non-Executive Director
6,000 -21.5%
163.01
US$978,060 		6,000 -21.5% 163.01 US$978,060
2013-12-02 2013-11-27 S Sale Wilkinson George Fred

PRES-ACTAVIS SPECIALTY BRANDS

Officer
24,217 -61.1%
165.00
US$3,995,805 		24,217 -61.1% 165.00 US$3,995,805
2013-11-27 2013-11-26 S Sale Mayr Charles M

Chief Communic Off-Global

Officer
10,000 -46.7%
162.60
US$1,626,000 		10,000 -46.7% 162.60 US$1,626,000
2013-11-26 2013-11-25 S Sale Wilkinson George Fred

PRES-ACTAVIS SPECIALTY BRANDS

Officer
1,502 -3.7%
165.00
US$247,830 		1,502 -3.7% 165.00 US$247,830
2013-11-26 2013-11-22 S Sale TURNER ANDREW L Non-Executive Director
2,500 -90.4%
163.45
US$408,625 		2,500 -90.4% 163.45 US$408,625
2013-11-26 2013-11-22 S Sale Wilkinson George Fred

PRES-ACTAVIS SPECIALTY BRANDS

Officer
4,281 -9.4%
165.00
US$706,365 		4,281 -9.4% 165.00 US$706,365
Explore more

More insider trading research around Allergan plc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America